PLANO, Texas – The U.S. Food and Drug Administration has cleared MEDICALgorithmics’ PocketECG Cardiac Rehabilitation System designed to provide high-quality electrocardiograph monitoring and automated arrhythmia detection during rehabilitation training. “We are thrilled to now introduce PocketECG CRS to patients and clinicians in the U.S., providing a valuable monitoring tool with the potential to improve the effectiveness of cardiac rehabilitation training,” said Marek Dziubinski, CEO of MEDICALgorithmics, in a statement. PocketECG CRS is a smartphone-sized device that monitors a patient’s heart rhythm and heart rate during rehabilitation exercises to safely guide the intensity and duration of workouts in real-time. The system transmits the full disclosure ECG signal classifying every heartbeat to automatically detect abnormalities and arrhythmia. A built-in accelerometer allows clinicians to analyze the impact of physical activity on heart rate. All data are streamed through a mobile telephony network to a secure online clinician portal and to a cardiac monitoring center for constant monitoring, evaluation and urgent notifications.
You are here: / / FDA clears portable ECG device